Regulatory T cells (T reg cells) have
and lower body weight (Fig. 1b) , and manifested a reduced body size, skin ulceration and crusting of ears and eyelids (Fig. 1c) . Moreover, the mutant mice had splenomegaly and lymphadenopathy ( Fig. 1d) and infiltration of immune cells in multiple organs (Fig. 1e) . Notably, despite largely normal morphology of the colon and caecum in Foxp3 
Stk11
fl/fl mice suggests that LKB1 has a crucial role in the function of T reg cells.
Among serum cytokines, levels of IL-4 and IL-5 were markedly elevated in Foxp3 cre Stk11 fl/fl mice ( Fig. 1f) , and MCP-1, TNF-α and IFN-γ were also increased (Extended Data Fig. 1d ). The titers of serum IgE and IgG1 (Fig. 1g) were much higher in Foxp3 cre Stk11 fl/fl mice than controls, and IgG2a/c, IgG2b, IgA and IgM levels were modestly upregulated (Extended Data Fig. 1e ). Moreover, Foxp3 cre Stk11 fl/fl mice had an increased frequency of eosinophils in the spleen and lung (Extended Data Fig. 1f, g ), but normal populations of splenic neutrophils and macrophages (Extended Data Fig. 1h, i) . Histological analysis revealed markedly increased numbers of eosinophils and Ym1 Fig. 3b ), but also higher levels of caspase-3 activity (Fig. 2b ) and expression of Bim (Fig. 2c) . The survival defects were observed in LKB1-deficient T reg cells from the mixed bone marrow chimaeras that avoided spontaneous inflammation ( 
fl/fl mice at 2 weeks old had a largely normal proportion of T reg cells (Extended Data Fig. 3e ) with normal expression of Bim (Extended Data Fig. 3f ). However, activation of T cells, infiltrations of immune cells into the lung, and elevation of serum IgE were appreciable in these mice (Extended Data Fig. 3g-i) . Depletion of Bim (encoded by Bcl2l11) in LKB1-deficient T reg cells substantially restored T reg cell cellularity (Extended Data Fig. 3j 
Bcl2l11
fl/fl mice (Extended Data Fig. 3l, m) . These results identify important roles of LKB1 in mediating both T reg cell survival and function.
The regulatory function is closely associated with signature molecules expressed by T reg cells 1, 2 . The negative co-receptor PD-1 and TNF receptor superfamily proteins GITR and OX40 were markedly elevated on LKB1-deficient T reg cells from Foxp3 cre Stk11 fl/fl mice (Extended Data Fig. 4a ) and mixed bone marrow chimaeras (Fig. 2f) , indicating cell-autonomous effects. By contrast, wild-type and LKB1-deficient T reg cells had largely comparable or slightly altered expression of CD62L, CD44 (Extended Data Fig. 4b) , GATA3, IRF4, T-bet, RORγ t (Extended Data Fig. 4c ), Foxp3, ICOS, CTLA-4 and CD25 (Extended Data  Fig. 4d, e) . The co-receptors PD-1, GITR and OX40 have been implicated in the control of T reg cell function and generation [8] [9] [10] [11] [12] [13] . 
Stk11
fl/fl mice) to delete Stk11 in T reg cells upon tamoxifen treatment 14 (Extended Data Fig. 4f ). Longer duration of LKB1 loss dimished T reg cells (Extended Data Fig. 4g ), associated with increased cell death (Extended Data Fig. 4h ), whereas T reg cells with acute deletion of LKB1 maintained intact homeostasis (Extended Data Fig. 4i ) and Bim expression (Fig. 2g) . In this setting of an inflammation-free environment (Extended Data Fig. 4j, k) , loss of LKB1 led to upregulated PD-1, GITR and OX40 expression (Fig. 2g) , without affecting Foxp3, ICOS and CD25 (Extended Data Fig. 4l ) or the distribution of resting and activated T reg subsets (Extended Data Fig. 4m ). Collectively, LKB1 acts in a cell-autonomous and direct manner to suppress a select group of T reg signature molecules.
Continuous T cell receptor (TCR) signalling drives T reg cell function in maintaining immune tolerance 15, 16 . Stimulation of T reg cells with anti-CD3 and anti-CD28 (anti-CD3/CD28) antibodies resulted in LKB1 phosphorylation and modestly increased LKB1 expression (Fig. 3a) . 
fl/fl T reg cells had slightly reduced mTORC1 activity under steady state (Fig. 3b) and largely normal phosphorylation of S6, AKT (S473) and FOXO1 upon anti-CD3/CD28 stimulation (Extended Data Fig. 5a, b) . Additionally, depletion of HIF-1α in LKB1-deficient T reg cells failed to rescue the defective T reg cell homeostasis or inflammatory disorder (Extended Data Fig. 5c-e) . 5′ AMP-activated protein kinase (AMPK) is a well-documented substrate of LKB1 (ref. 5), the activation of which was lost in LKB1-deficient T reg cells (Extended Data Fig. 5f ). Nonetheless, deletion of AMPKα 1 and AMPKα 2 in T reg cells did not affect T reg cell proportion or immmune homeostasis (Fig. 3c, Extended Data Fig. 5g, h ). Taken together, these results show that LKB1 is activated by TCR signalling in T reg cells but functions independently of mTORC1-HIF-1α axis or AMPK signalling.
In the transcriptome of wild-type and LKB1-deficient T reg cells from the mixed bone marrow chimaeras, gene set enrichment analysis (GSEA) showed that LKB1 deficiency impaired gene expression implicated in multiple metabolic pathways (Extended Data Fig. 6a ), including tricarboxylic acid (TCA) cycle and mitochondrial protein import (Extended Data Fig. 6b, c) . Unbiased metabolomic profiling in activated Foxp3 cre Stk11 fl/fl T reg cells (Extended Data Fig. 6d ) revealed a marked reduction of metabolic intermediates associated with mitochondrial function including TCA cycle and fatty acid β -oxidation, as well as those in purine and pyrimidine metabolism, whereas metabolites in glycolysis were not uniformly altered (Fig. 3d , Extended Data Fig. 6e, f) . Notably, histamine was increased in LKBdeficient T reg cells (Fig. 3e) . Histidine decarboxylase, an enzyme that converts histidine to histamine, was increased in LKB1-deficient T reg cells (Fig. 3f) . As histamine has been implicated in suppressing T reg cell function 19 , an increased production of histamine in LKBdeficient T reg cells could contribute to their defects in an autocrine manner. Metabolite set enrichment analysis indicated that LKB1 deficiency in T reg cells downregulated multiple metabolic programs, but upregulated the pathway for biosynthesis of unsaturated fatty acids (Fig. 3g ). LKB1-deficient T reg cells had defective mitochondrial fitness, indicated by reduced mitochondrial mass, mitochondrial membrane potential, and reactive oxygen species (Extended Data (Fig. 4c) , suggesting that LKB1-deficient T reg cells fail to control maturation of PD-L2 + DCs. In support of this, wild-type T reg cells inhibited the induction of PD-L2, CD80 and CD86 on DCs primed with TSLP (TSLP-DCs), whereas LKB1-deficient T reg cells did not (Fig. 4d, Extended Data Fig. 8c ). Furthermore, TSLP-DCs polarized the differentiation of naive CD4 + T cells into T H 2 cells, which was effectively suppressed by wild-type but not LKB1-deficient T reg cells (Fig. 4e, Extended Data Fig. 8d ). By contrast, LKB1-sufficient and -deficient T reg cells were equally capable of suppressing T H 1 cell differentiation driven by LPS-primed DCs (Extended Data Fig. 8e, f) . Therefore, T reg cells require LKB1 to repress maturation of TSLP-DCs and subsequent induction of T H 2 responses.
To test the physiological relevance of LKB1-mediated regulatory mechanisms in T H 2 responses, we examined the expression of PD-1, GITR and OX40 on T reg cells from mice challenged with ovalbumin (OVA)-induced allergic airway inflammation. OVA inhalation elicited the expression of these factors on T reg cells in the lung (Extended Data  Fig. 9a ), but not those in the spleen (Extended Data Fig. 9b ). Given the unique and potent roles of PD-1 in T cells for immune modulation and therapy 22 , we hypothesized that aberrant induction of PD-1 on LKB1-deficient T reg cells disrupts their function in suppressing T H 2 responses. We tested this hypothesis using gain-and loss-of-function approaches. First, ectopic expression of PD-1 impaired the capability of T reg cells in suppressing T H 2 cell differentiation (Extended Data  Fig. 9c) . Second, PD-1 deficiency promoted T reg -mediated suppression of T H 2 responses (Extended Data Fig. 9d) . Third, to examine the function of PD-1-deficient T reg cells in vivo, we generated mixed bone marrow chimaeras using bone marrow cells from T reg -deficient Scurfy mice, together with those from wild-type or Pdcd1 -/-mice. Scurfy-Pdcd1 -/-chimaeras had a reduced proportion of lung and spleen eosinophils (Extended Data Fig. 9e ) and concentration of serum IgG1 (Extended Data Fig. 9f ), but normal concentration of IgG2a/c (Extended Data Fig. 9f ). Finally, blocking PD-1 and its ligands largely reversed the defect of LKB1-deficient T reg cells in suppressing T H 2 cell differentiation (Fig. 4f) . Therefore, LKB1 restrains PD-1 expression as an important mechanism to ensure the functional integrity of T reg cells in repressing T H 2 responses.
We next explored how LKB1 regulates PD-1 and other T reg signature molecules. Wnt signalling, which is implicated in T H 2-mediated inflammation 23 and T reg cell survival and function 24, 25 , was significantly underrepresented in gene sets from LKB1-deficient T reg cells (Extended Data Fig. 10a ). Activated wild-type T reg cells upregulated the expression of β -catenin, a key mediator of Wnt signalling, while the induction was attenuated in LKB1-deficient T reg cells (Fig. 4g) . Aside from the modestly reduced β -catenin (Ctnnb1) mRNA (Extended Data Fig. 10b ), LKB1-deficient T reg cells had increased phosphorylation of β -catenin that mediates its degradation (Extended Data Fig. 10c ). Moreover, β -catenin bound to a T-cell factor 3 (TCF3) motif in the Pdcd1 locus in wild-type T reg cells, but this binding was lost in LKB1-deficient T reg cells (Extended Data Fig. 10d ). Expression of constitutively active β -catenin by retrovirus (β -cat-RV) reversed the aberrant expression of PD-1 and GITR on LKB1-deficient T reg cells (Fig. 4h , Extended Data Fig. 10e ), but did not affect CD25 expression (Extended Data Fig. 10e ) or survival of T reg cells (data not shown). Similar rescue effects were observed in β -catenin-expressing T reg cells after acute deletion of LKB1 (Extended Data Fig. 10f ). Moreover, β -cat-RV substantially rectified the defects of LKB1-deficient T reg cells in suppressing DC expression of PD-L2, CD80 and CD86 (Extended Data Fig. 10g ) and T H 2 cell differentiation polarized by TSLP-DCs (Fig. 4i) . Collectively, these results indicate an important role of the LKB1-β -catenin signalling axis in the control of T H 2 responses through modulating PD-1 and T reg cell signature molecules. 
letter reSeArCH
Emerging studies highlight the importance of metabolic reprogramming in immune cell activation and differentiation
26
, but how metabolism and immune function are integrated and especially homeostatic control mechanisms remain poorly defined. Here we identify LKB1 as a crucial checkpoint to maintain T reg cell survival and function through coordinating metabolic and functional fitness of T reg cells (Extended Data Fig. 10h ). LKB1 connects immunological signals and cellular metabolism including mitochondrion-related functions. Furthermore, LKB1 curtails the aberrant induction of PD-1, GITR and OX40 in a β -catenin dependent manner, and blockade of PD-1 signalling reinvigorates the ability of LKB1-deficient T reg cells in the repression of T H 2 responses. PD-1 upregulation and metabolic alteration have long been observed in exhausted CD8
+ T cells 27 , and increasing evidence reveals the interplay between immune checkpoints and cell metabolism [28] [29] [30] . Our results suggest that T reg cells not only exist at a resting or activated state 1 , but could also undergo functional exhaustion. Given the constitutive expression of the epithelial cytokine TSLP and the ensuing stimulation of DCs at the environmental interface, T reg cells require LKB1 to actively maintain their metabolic and immunological homoeostasis, the loss of which results in the apoptotic and functional exhaustion of T reg cells. Our findings point to a previously unrecognized mechanism enforcing homeostatic control of T reg cells, and provide a framework to further understand integration of metabolic signalling and lymphocyte fate and state.
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Stk11
fl/fl mice were used at 3-5 weeks old unless otherwise noted, with the age-and gender-matched wild-type mice containing the Foxp3 cre allele as controls. Other mice were used at 8-10 weeks old unless otherwise noted. Bone marrow chimaeras were generated by transferring 1 × 10 7 T-cell-depleted bone marrow cells into sub-lethally irradiated (5.5 Gy) Rag1 -/-mice, followed by reconstitution for at least 2 months. For tamoxifen administration, mice were injected intraperitoneally with tamoxifen (2 mg per mouse) in corn oil every other day for 6 times, and then analysed 6-7 days after the last injection (unless otherwise noted). All mice were kept in a specific pathogen-free facility in the Animal Resource Center at St Jude Children's Research Hospital, and animal protocols were approved by the Institutional Animal Care and Use Committee. ; 2C11, Bio X Cell) and anti-CD28 (5 μ g ml −1
; 37.51, Bio X Cell) for the indicated time points. For T cell differentiation in vitro, splenic DCs from C57BL/6 mice were stimulated with TSLP 31 (10 ng ml ) for 18 h, and then washed with HBSS containing 2% FBS twice before co-culturing with naive CD4 + T cells and T reg cells in the presence of 1 μ g ml −1 CD3 antibody for an additional 5 days. To block PD-1 signalling, control IgG (30 μ g ml
) or a mixture of blocking antibodies against PD-1 (10 μ g ml ; J43, eBioscience), PD-L1 (10 μ g ml ; MIH5, eBioscience) and PD-L2 (10 μ g ml ; TY25, eBioscience) were added. At the end of culture, viable cells were purified using Ficoll and stimulated for 4 h with PMA plus ionomycin in the presence of monensin, before intracellular staining of cytokines was performed. Constitutively active β -catenin constructs 32 were generated by PCR and cloned into the mouse stem cell virus retroviral vector. Retroviral packaging and transduction were performed as described previously 33 . RNA and immunoblot analysis. Real-time PCR analysis was performed with probe sets Stk11 (Mm00488473_g1), Hdc (Mm00456104_m1), Ctnnb1 (Mm00483039_m1), and Actb (Mm00607939_s1) (all from ThermoFisher Scientific). Immunoblots were performed and quantified as described previously 34 , using the following antibodies: phospho-LKB1 (Ser428; C67A3), LKB1 (D60C5), β -catenin (D10A8), phospho-β -catenin (Ser33/37/Thr41), phospho-S6 (Ser235/236; D57.2.2E), phospho-AKT (Ser473; D9E), phospho-FOXO1 (Ser256), phospho-AMPK (Thr172) (all from Cell Signaling Technology), and β -actin (Sigma). ) and anti-CD28 (5 μ g ml
Metabolomics analysis. T reg cells from
) for 48 h, followed by extensive wash with PBS. Metabolites were extracted from cell pellets and culture medium using 80% methanol containing 0.05 ng μ l −1 inosine-15N4 and 0.05 ng μ l −1 thymine-d4 as internal standards (Cambridge Isotope Laboratories). The samples were centrifuged (10 min, 9,000g, 4 °C) and the supernatants were collected. Three liquid chromatography tandem mass spectrometry (LC-MS) systems were used to profile metabolites. Negative-ion-targeted profiling of polar metabolites was performed using an ACQUITY UPLC (Waters Corp) coupled to a 5500 QTRAP triple quadrupole mass spectrometer (AB SCIEX). Extracts (10 μ l) were injected directly onto a 150 × 2.0 mm Luna NH2 column (Phenomenex). The column was eluted at a flow rate of 400 μ l min −1 with initial conditions of 10% mobile phase A (20 mM ammonium acetate and 20 mM ammonium hydroxide (Sigma-Aldrich) in water (VWR)) and 90% mobile phase B (10 mM ammonium hydroxide in 75:25 v/v acetonitrile/methanol (VWR)) followed by a 10 min linear gradient to 100% mobile phase A. The ion spray voltage was − 4.5 kV and the source temperature was 500 °C. Positive ionization mode profiling of polar metabolites was performed using a Nexera X2 U-HPLC (Shimadzu)-Q Exactive Orbitrap (Thermo Fisher Scientific) LC-MS system. The 80% methanol extracts (100 μ l) were dried using a nitrogen evaporator (TurboVap LV; Biotage) and then resuspended in 10 μ l of water and 90 μ l of 74.9:24.9:0.2 vol/vol/vol acetonitrile/methanol/formic acid containing stable isotope-labelled internal standards (valine-d8, Isotec; and phenylalanine-d8, Cambridge Isotope Laboratories). The samples were centrifuged (10 min, 9,000g, 4 °C) and the supernatants were injected directly onto a 150 × 2 mm Atlantis HILIC column (Waters). The column was eluted isocratically at a flow rate of 250 μ l min −1 with 5% mobile phase A (10 mM ammonium formate and 0.1% formic acid in water) for 1 min followed by a linear gradient to 40% mobile phase B (acetonitrile with 0.1% formic acid) over 10 min. The electrospray ionization voltage was 3.5 kV and data were acquired using full scan analysis over m/z 70-800 at 70,000 resolution. Reversed-phase C18 chromatography/negative ion mode mass spectrometry analyses of free fatty acids and bile acids were conducted using an LC-MS system comprised of a Shimadzu Nexera X2 U-HPLC (Shimadzu Corp.) coupled to a Q Exactive hybrid quadrupole orbitrap mass spectrometer (Thermo Fisher Scientific). Medium (30 μ l) was extracted using 90 μ l of methanol containing PGE2-d4 (Cayman Chemical Co.) and centrifuged (10 min, 9,000g, 4 °C) and the cell extracts were analysed directly. The samples were injected onto a 150 × 2.1 mm ACQUITY BEH C18 column (Waters). The column was eluted isocratically at a flow rate of 450 μ l min −1 with 80% mobile phase A (0.01% formic acid in water) for 3 min followed by a linear gradient to 100% mobile phase B (acetonitrile with 0.01% acetic acid) over 12 min. MS analyses were carried out in the negative ion mode using electrospray ionization, full-scan MS acquisition over 70-850 m/z, and a resolution setting of 70,000. Metabolite identities were confirmed using authentic reference standards. Other mass spectrometry settings were: spray voltage − 3.5 kV, capillary temperature 320 °C, and heater temperature 300 °C. LC-MS data were processed and visually inspected using MultiQuant 2.1 (SCIEX) and TraceFinder 3.1 software (Thermo Fisher Scientific). Metabolite set enrichment analysis was performed as described previously 14 C] glucose (Perkin Elmer) was added to the cells for the final 8 h of culture. Cells were lysed in 0.5% Triton X-100, and the lipid fraction was extracted by addition of chloroform and methanol (2:1 v/v) with vortexing, followed by addition of water with vortexing. After centrifugation, the lipid-containing phase was obtained and 14 C incorporation was measured with a Beckman LS6500 scintillation counter. Oxygen consumption rate and extracellular acidification rate were measured in XF media (non-buffered DMEM containing 5 mM glucose, 2 mM l-glutamine and 1 mM sodium pyruvate), under basal conditions and in response to 1 μ M oligomycin, 2 μ M fluoro-carbonyl cyanide phenylhydrazone (FCCP), 200 μ M Etomoxir (Eto) and 1 μ M rotenone/ antimycin A (Rot/AA) using the XF-24 Extracellular Flux Analyzer (Seahorse Bioscience). Intracellular levels of ATP in T reg cells were measured using luminescent ATP detection assay kit (Abcam). Gene expression profiling. RNA samples from donor-derived T reg cells from CD45.1 + wild-type and CD45.1 + Foxp3 cre Stk11 fl/fl mixed bone marrow chimaeras (n = 5 each group) were analysed using the Mouse Gene 2.0 ST Signals array. Differentially expressed transcripts were identified by ANOVA (Partek Genomics Suit 6.5), and the Benjamini-Hochberg method was used to estimate the false discovery rate (FDR). Gene set enrichment analysis (GSEA) was performed as letter reSeArCH described previously 36 . The microarray data have been deposited in the Gene Expression Omnibus under accession number GSE83088. Serum antibodies. Immunoglobulin subclasses were measured with kits from Alpha Diagnostic International (5110) and Millipore (MGAMMAG-300K), respectively 36 . OVA-induced allergic airway inflammation. Mice were sensitized with mixture of OVA (50 μ g ml −1 per mouse) and alum adjuvant (1:2 dilution) injected intraperitoneally (100 μ l per mouse), followed by the second sensitization 12 days later. Eight days after the second sensitization, mice were intranasally challenged with OVA for 4 consecutive days. At 18 h after the last challenge, lymphocytes were isolated from the spleen and lung and analysed by flow cytometry. Chromatin immunoprecipitation (ChIP). ChIP methodology was performed as described 37, 38 . Briefly, cells were cross-linked for 40 min using 12.5 μ M ethylene glycol-bis(succinimidyl succinate) (ThermoFisher Scientific), followed by the addition of formaldehyde (1% final concentration) and incubation for additional 20 min. After the reactions were quenched with glycine, cell pellets were lysed in cell lysis buffer (25 mM HEPES pH 7.8, 1.5 mM MgCl 2 , 10 mM KCl, 0.3% NP-40 and 1 mM DTT) containing a protease inhibitor tablet (Roche) for 10 min on ice. Nuclei were pelleted and lysed in nuclear lysis buffer (50 mM HEPES, pH 7.9, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.2% SDS) containing a protease inhibitor tablet for 10 min on ice, before sonication into 500-bp pieces using a Diagenode Bioruptor. Sheared chromatin was cleared of debris and incubated with IgG (Santa Cruz) or anti-β -catenin antibody (Cell Signaling; 1:50) and blocker (Active Motif) rotating overnight at 4 °C. Chromatin immunoprecipitation and subsequent DNA purification were performed using the ChIP-IT High Sensitivity Kit (Active Motif) per manufacturer's instructions. Real-time PCR was performed using the primers spanning the TCF3 motif in the Pdcd1 locus (http://rstats.immgen.org/Chromatin/ chromatin.html): forward, 5′ -GGAAACAGGCACCAAGACAT-3′ , reverse, 5′ -CTACTCAATCCGTGGGAGGA-3′ , and negative control primer sets (Active Motif 71011). Data analysis was performed using the 'Percent Input' normalization method. Statistical analysis. P values were calculated by Mann-Whitney test, two-tailed unpaired Student's t-test, one-way ANOVA or two-way ANOVA as indicated using GraphPad Prism, unless otherwise noted. Statistical analysis of mouse survival and respective P values were determined using the log-rank test. P < 0.05 was considered as significant. All error bars represent the s.e.m. Data availability. The microarray data that support the findings of this study have been deposited in the Gene Expression Omnibus under accession number GSE83088. Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
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